Pages that link to "Q39986534"
Jump to navigation
Jump to search
The following pages link to Estrogens and Endometrial Cancer in a Retirement Community (Q39986534):
Displaying 50 items.
- Hormone therapy in postmenopausal women and risk of endometrial hyperplasia (Q24201543) (← links)
- Hormone therapy in postmenopausal women and risk of endometrial hyperplasia (Q24241713) (← links)
- Hormone therapy in postmenopausal women and risk of endometrial hyperplasia (Q24246573) (← links)
- A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk (Q24535819) (← links)
- Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy (Q28318588) (← links)
- The Effect of Oestradiol Valerate Therapy on Coagulation Factors and Lipid and Oestrogen Levels in Oöphorectomised Women (Q28323762) (← links)
- The cancer question: an overview of recent epidemiologic and retrospective data (Q31048529) (← links)
- Sampling for conditional inference on case-control data (Q31126613) (← links)
- Special considerations in breast cancer risk and survival (Q33707212) (← links)
- Estrogen therapy in postmenopausal women (Q34050683) (← links)
- Obstetrics and gynecology: menopause (Q34050804) (← links)
- Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort (Q34078827) (← links)
- Hormone replacement therapy and the endometrium (Q34263283) (← links)
- Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women (Q34290050) (← links)
- Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits (Q34370222) (← links)
- Gallstones and the risk of cancer (Q34494141) (← links)
- Prescribing estrogen during menopause: physician survey of practices in 1974 and 1981. (Q34506823) (← links)
- Exogenous estrogen and endometrial carcinoma: Case-control and incidence study (Q34905835) (← links)
- Perimenopausal use of reproductive hormones effects on breast and endometrial cancer (Q34920011) (← links)
- Investigation of a family suspected of being at high risk for cancer (Q35228249) (← links)
- Estrogens and endometrial cancer: some answers and some further questions (Q35229739) (← links)
- The menopause and hormone replacement therapy (Q35536861) (← links)
- Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease (Q35617626) (← links)
- Mortality for cancer of the corpus uteri (Q35673501) (← links)
- Hormone replacement treatment (Q35712507) (← links)
- Postmenopausal oestrogen treatment and stroke: a prospective study (Q35730469) (← links)
- Recent time-trends of age-specific death rates for breast cancer: Quebec and other provinces, 1965 through 1974. (Q35815836) (← links)
- The rationale for low-dose hormonal therapy (Q35948662) (← links)
- The epidemiology of endometrial cancer in young women (Q36047673) (← links)
- Sex Steroids and Cancer in Older Women (Q36215680) (← links)
- Alternative data sources in a case-control study of conjugated estrogens and cancer. (Q36341343) (← links)
- Relationships of uterine and ovarian tumors to pre-existing chronic conditions (Q36382387) (← links)
- The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk (Q36465880) (← links)
- Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study (Q36467341) (← links)
- Combination therapy for osteoporosis with estrogen, fluoride, and calcium (Q36644808) (← links)
- Estrogens in the postmenopausal woman (Q36651334) (← links)
- Diagnosis and management of involutional osteoporosis. (Q36656266) (← links)
- Estrogen replacement therapy (ERT) in high-risk cancer patients (Q36988226) (← links)
- The endometrium--from estrogens alone to TSECs (Q37631061) (← links)
- Hypertension and the risk of endometrial cancer: a systematic review and meta-analysis of case-control and cohort studies (Q37741429) (← links)
- The pathogenesis of endometrial carcinomas at menopause: facts and figures (Q37844330) (← links)
- Nurse-researchers respond to the medicalization of menopause (Q37943179) (← links)
- A risk-benefit assessment of estrogen therapy in postmenopausal women (Q37974171) (← links)
- Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women (Q38381450) (← links)
- Estrogen-Progestin Replacement Therapy and Endometrial Cancer (Q38504098) (← links)
- Urinary tract infections and estrogen use in older women (Q38513753) (← links)
- Estrogen replacement therapy: indications, contraindications, and agent selection (Q38746808) (← links)
- Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences (Q38788210) (← links)
- Menopausal oestrogen therapy and protection from death from ischaemic heart disease (Q39340048) (← links)
- HRT and osteoporosis (Q39490443) (← links)